Unihealth Hosp

When is the next results date for Unihealth Hosp?

No Upcoming Board Meetings

Has Unihealth Hosp declared dividend?

No Dividend History Available

Who are the peers of the Unihealth Hosp?

Unihealth Hosp's peers include Chandan Healthca, Aprameya Enginee, Nephro Care, KHFM Hospitality, Maitreya Medica, Vaidya Sane, Asarfi Hospital, Aashka Hospitals, Abate As Indust, and KMC Speciality. In terms of performance, Unihealth Hosp has a 1-year return of 35.24%, with varying management and growth risks among its peers.

Peers: The peers of Unihealth Hosp are Chandan Healthca, Aprameya Enginee, Nephro Care, KHFM Hospitality, Maitreya Medica., Vaidya Sane, Asarfi Hospital, Aashka Hospitals, Abate As Indust, and KMC Speciality.<BR><BR>Quality Snapshot: Excellent management risk is observed at Chandan Healthca, while Good management risk is found at Aprameya Enginee, Nephro Care, Unihealth Hosp, and Asarfi Hospital. Average management risk is noted at KHFM Hospitality and Maitreya Medica., while Below Average management risk is seen at Vaidya Sane and Aashka Hospitals. The rest, including Abate As Indust, does not qualify. Excellent growth is demonstrated by Chandan Healthca and Nephro Care, while Good growth is observed at Unihealth Hosp and Vaidya Sane. Average growth is found at Aprameya Enginee, KHFM Hospitality, and Maitreya Medica., while Below Average growth is noted at Asarfi Hospital, Aashka Hospitals, and the rest. Capital Structure ratings show Good at Chandan Healthca, Nephro Care, Maitreya Medica., and Asarfi Hospital, while Below Average is seen at Unihealth Hosp, KHFM Hospitality, and Aashka Hospitals, with the rest not qualifying.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Maitreya Medica. at 119.67%, while Nephro Care has the lowest at -46.62%. Unihealth Hosp's 1-year return is 35.24%, which is significantly higher than Nephro Care but lower than Maitreya Medica. Additionally, Nephro Care, Maitreya Medica., and KHFM Hospitality have negative six-month returns.

What does Unihealth Hosp do?

Unihealth Hospitals Ltd operates in the hospital industry as a micro-cap company, having transitioned from a private to a public entity in 2023. Key financial metrics include a market cap of INR 263 Cr, a P/E ratio of 17.00, and a return on equity of 17.72%.

Overview: <BR>Unihealth Hospitals Ltd operates in the hospital industry and is categorized as a micro-cap company.<BR><BR>History: <BR>Unihealth Consultancy Limited was incorporated in 2010 under the name "Unihealth Consultancy Private Limited." The company status changed to Public Limited, and its name was updated to "Unihealth Consultancy Limited" on April 26, 2023. Revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 263 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 17.00 <BR>Industry P/E: 59 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.16 <BR>Return on Equity: 17.72% <BR>Price-to-Book: 3.08 <BR><BR>Contact Details: <BR>Address: Not available <BR>Phone: Not available <BR>Email: Not available <BR>Website: Not available

Who are the top shareholders of the Unihealth Hosp?

The top shareholder of Unihealth Hosp is Anurag Ratan Kumar Sha, holding 32.47% of the shares, with Anant Wealth Consultants as the largest public shareholder at 3.94%. Individual investors collectively own 20.78%, and there are no pledged promoter holdings or shares held by mutual funds or foreign institutional investors.

The top shareholders of Unihealth Hosp include the promoters, with Anurag Ratan Kumar Sha holding the largest share at 32.47%. There are no pledged promoter holdings, and mutual funds and foreign institutional investors do not hold any shares in the company. The highest public shareholder is Anant Wealth Consultants, which holds 3.94%. Additionally, individual investors collectively own 20.78% of the shares.

How big is Unihealth Hosp?

As of 24th July, Unihealth Hospitals Ltd has a market capitalization of 271.00 Cr, classified as a Micro Cap, with Shareholder's Funds of 85.45 Cr and Total Assets of 110.21 Cr; however, no valid financial data is available for the latest four quarters.

As of 24th July, <BR><BR>Market Cap: Unihealth Hospitals Ltd has a market capitalization of 271.00 Cr, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: No valid financial data is available for the latest four quarters, including Net Sales and Net Profit.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds amounting to 85.45 Cr and Total Assets totaling 110.21 Cr.

How has been the historical performance of Unihealth Hosp?

Unihealth Hosp has demonstrated consistent growth in net sales and profitability over the past five years, with net sales increasing from 26.21 Cr in Mar'21 to 55.59 Cr in Mar'25, and profit after tax rising from 4.95 Cr to 15.15 Cr. However, cash flow from operating activities turned negative in Mar'25, indicating recent challenges.

Answer:<BR>The historical performance of Unihealth Hosp shows a consistent growth trend in net sales and profitability over the past five years.<BR><BR>Breakdown:<BR>Unihealth Hosp's net sales have increased from 26.21 Cr in Mar'21 to 55.59 Cr in Mar'25, demonstrating a strong upward trajectory. Total operating income followed a similar pattern, rising to 55.59 Cr in Mar'25 from 26.21 Cr in Mar'21. The company’s total expenditure, excluding depreciation, also grew, reaching 37.10 Cr in Mar'25, up from 19.69 Cr in Mar'21. Operating profit (PBDIT) has shown significant improvement, climbing from 8.95 Cr in Mar'21 to 21.31 Cr in Mar'25. Profit before tax increased from 5.47 Cr in Mar'21 to 17.28 Cr in Mar'25, while profit after tax rose from 4.95 Cr to 15.15 Cr in the same period. The consolidated net profit also reflected this growth, moving from 5.01 Cr in Mar'21 to 15.14 Cr in Mar'25. The company's total assets increased from 58.34 Cr in Mar'21 to 132.09 Cr in Mar'25, with total liabilities rising from 58.39 Cr to 132.09 Cr. However, cash flow from operating activities turned negative in Mar'25 at -3.00 Cr, contrasting with positive cash flows in previous years. Overall, Unihealth Hosp has shown robust growth in sales and profitability, despite recent challenges in cash flow.

Is Unihealth Hosp technically bullish or bearish?

As of December 1, 2025, Unihealth Hosp's trend is mildly bullish, supported by a bullish MACD and moving averages, though bearish RSI readings suggest some momentum weakness.

As of 1 December 2025, the technical trend for Unihealth Hosp has changed from bullish to mildly bullish. The current stance is mildly bullish, with key indicators supporting this view. The weekly MACD remains bullish, while the daily moving averages also indicate a bullish trend. However, the weekly and monthly RSI readings are bearish, suggesting some weakness in momentum. The Bollinger Bands are bullish on both weekly and monthly time frames, providing additional support. Overall, the mixed signals from the RSI and MACD indicate a cautious bullish sentiment.

Is Unihealth Hosp overvalued or undervalued?

As of December 3, 2025, Unihealth Hospital is considered undervalued with an attractive valuation grade, highlighted by a PE Ratio of 33.89, strong growth metrics, and significant recent performance, outperforming peers like Max Healthcare and Apollo Hospitals.

As of 3 December 2025, the valuation grade for Unihealth Hosp has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued based on its financial metrics. Key ratios include a PE Ratio of 33.89, an EV to EBITDA of 13.29, and a PEG Ratio of 0.94, which suggests that the stock is priced favorably relative to its growth prospects.<BR><BR>In comparison to its peers, Unihealth Hosp stands out with a significantly lower PE Ratio than Max Healthcare, which is at 74.7, and Apollo Hospitals, which has a PE of 61.84. This positions Unihealth as an attractive option in the hospital sector, especially considering its strong ROCE of 22.89% and ROE of 11.27%. Notably, while the stock has experienced a decline of 16.95% over the past week, it has shown impressive growth of 90.36% over the last month, outperforming the Sensex, which only increased by 0.86% in the same period.

Why is Unihealth Hospitals Ltd falling/rising?

As of 02-Apr, Unihealth Hospitals Ltd's stock price is at 393.95, reflecting a 3.53% increase. The stock has shown strong performance, rising 31.71% year-to-date and trading above its moving averages, indicating positive momentum despite a recent decline in investor participation.

As of 02-Apr, Unihealth Hospitals Ltd's stock price is rising, currently at 393.95, reflecting an increase of 13.45 or 3.53%. This upward movement can be attributed to several factors. The stock has shown strong performance over the past month, with a remarkable increase of 18.48%, significantly outperforming the benchmark Sensex, which declined by 8.66% during the same period. Year-to-date, the stock has risen by 31.71%, while the Sensex has fallen by 13.08%, indicating a robust relative strength.<BR><BR>Additionally, the stock is trading above its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which is typically a positive indicator of momentum. Furthermore, the stock is close to its 52-week high, being only 4.07% away from the peak of Rs 410. Despite a recent decline in investor participation, with delivery volume falling by 15.38% against the 5-day average, the overall performance metrics suggest that the stock is currently in a favorable position, contributing to its rising price.

Which are the latest news on Unihealth Hosp?